We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · February 19, 2023

Safety and Impact of MiniMed 780G™ in 2- to 6-Year-Old Children

Diabetes Technology & Therapeutics


Additional Info

Diabetes Technology & Therapeutics
MiniMed 780G™ in 2- to 6-Year-Old Children: Safety and Clinical Outcomes After the First 12 Weeks
Diabetes Technol. Ther. 2023 Feb 01;25(2)100-107, MA Pulkkinen, TJ Varimo, ET Hakonen, MH Harsunen, ME Hyvönen, JN Janér, SM Kiiveri, HM Laakkonen, SM Laakso, K Wehkalampi, MT Hero, PJ Miettinen, AK Tuomaala

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading